Suppr超能文献

利用尿液中的葡萄糖醛酸乙酯检测酒精依赖门诊患者的轻度和重度饮酒情况。

Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients.

作者信息

McDonell Michael G, Skalisky Jordan, Leickly Emily, McPherson Sterling, Battalio Samuel, Nepom Jenny R, Srebnik Debra, Roll John, Ries Richard K

机构信息

Initiative for Research and Education to Advance Community Health (I-REACH), Washington State University, Box 1495, Spokane, WA 99210, United States.

Initiative for Research and Education to Advance Community Health (I-REACH), Washington State University, Box 1495, Spokane, WA 99210, United States.

出版信息

Drug Alcohol Depend. 2015 Dec 1;157:184-7. doi: 10.1016/j.drugalcdep.2015.10.004. Epub 2015 Oct 9.

Abstract

AIMS

This study investigated which ethyl glucuronide immunoassay (EtG-I) cutoff best detects heavy versus light drinking over five days in alcohol dependent outpatients.

METHODS

A total of 121 adults with alcohol use disorders and co-occurring psychiatric disorders took part in an alcohol treatment study. Participants provided self-reported drinking data and urine samples three times per week for 16-weeks (total samples=2761). Agreement between low (100 ng/mL, 200 ng/mL), and moderate (500 ng/mL) EtG-I cutoffs and light (women ≤3 standard drinks, men ≤4 standard drinks) and heavy drinking (women >3, men >4 standard drinks) were calculated over one to five days.

RESULTS

The 100 ng/mL cutoff detected >76% of light drinking for two days, and 66% at five days. The 100 ng/mL cutoff detected 84% (1 day) to 79% (5 days) of heavy drinking. The 200 ng/mL cutoff detected >55% of light drinking across five days and >66% of heavy drinking across five days. A 500 ng/mL cutoff identified 68% of light drinking and 78% of heavy drinking for one day, with detection of light (2-5 days <58%) and heavy drinking (2-5 days <71%) decreasing thereafter. Relative to 100 ng/mL, the 200 ng/mL and 500 ng/mL cutoffs were less likely to result in false positives.

CONCLUSIONS

An EtG-I cutoff of 100 ng/mL is most likely to detect heavy drinking for up to five days and any drinking during the previous two days. Cutoffs of ≥500 ng/mL are likely to only detect heavy drinking during the previous day.

摘要

目的

本研究调查了哪种乙醇葡糖苷酸免疫分析法(EtG-I)临界值能在酒精依赖门诊患者的五天时间里最佳地检测出重度饮酒与轻度饮酒情况。

方法

共有121名患有酒精使用障碍并伴有精神疾病的成年人参与了一项酒精治疗研究。参与者每周提供三次自我报告的饮酒数据和尿液样本,为期16周(样本总数=2761)。计算了低(100纳克/毫升、200纳克/毫升)和中度(500纳克/毫升)EtG-I临界值与轻度饮酒(女性≤3标准杯,男性≤4标准杯)和重度饮酒(女性>3,男性>4标准杯)在1至5天内的一致性。

结果

100纳克/毫升的临界值在两天内检测出>76%的轻度饮酒情况,五天时为66%。100纳克/毫升的临界值检测出重度饮酒的比例为84%(1天)至79%(5天)。200纳克/毫升的临界值在五天内检测出>55%的轻度饮酒情况,五天内检测出>66%的重度饮酒情况。500纳克/毫升的临界值在一天内识别出68%的轻度饮酒和78%的重度饮酒情况,此后检测轻度饮酒(2 - 5天<58%)和重度饮酒(2 - 5天<71%)的比例下降。相对于100纳克/毫升,200纳克/毫升和500纳克/毫升的临界值产生假阳性的可能性较小。

结论

100纳克/毫升的EtG-I临界值最有可能检测出长达五天的重度饮酒情况以及前两天内的任何饮酒情况。≥500纳克/毫升的临界值可能仅能检测出前一天的重度饮酒情况。

相似文献

引用本文的文献

2
Wearable Sensors for Physiological Condition and Activity Monitoring.用于生理状况和活动监测的可穿戴传感器。
Small Sci. 2024 May 18;4(7):2300358. doi: 10.1002/smsc.202300358. eCollection 2024 Jul.
4
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder.酒精使用障碍药物治疗试验的终点。
Pharmaceut Med. 2024 Jul;38(4):291-302. doi: 10.1007/s40290-024-00526-x. Epub 2024 Jul 5.
5
Novel medications for problematic alcohol use.新型治疗酒精使用障碍的药物
J Clin Invest. 2024 Jun 3;134(11):e172889. doi: 10.1172/JCI172889.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验